Medicare Drug Negotiation and Rebate Group Formally Organized

Oct. 12, 2022, 9:22 PM UTC

The Biden administration has formally established the Medicare Drug Rebate and Negotiations Group to implement Medicare drug price negotiations and the inflation rebate program authorized under the Inflation Reduction Act of 2022.

Operating within the Center for Medicare, the new group, and the reorganization it required, was approved by HHS Secretary Xavier Becerra and took effect Oct. 8, according to a summary document released Wednesday that will be published in the Federal Register Oct. 14.

The Inflation Reduction Act (H.R. 5376), signed by President Joe Biden Aug. 16, requires drug companies beginning in 2023 to pay rebates to ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.